Matthew Fronheiser
About Matthew Fronheiser
Matthew Fronheiser is the Cardiovascular Imaging Lead in Translational Sciences at Bristol-Myers Squibb, with a strong background in biomedical engineering and over a decade of experience at the company.
Current Role at Bristol-Myers Squibb
Matthew Fronheiser currently holds the position of Cardiovascular Imaging Lead in the Translational Sciences division at Bristol-Myers Squibb. He has been with the company for over a decade, starting his tenure in December 2009. In his role, he focuses on cardiovascular imaging, contributing his expertise to advance translational sciences within the organization.
Professional Experience in Biomedical Engineering
Matthew Fronheiser brings a robust background in biomedical engineering to his current role. His professional journey includes a two-year tenure at Seno Medical from 2007 to 2009, where he worked as an engineer on various projects. Prior to that, he gained valuable research experience as a Graduate Research Assistant at Duke University, where he worked from 2002 to 2007.
Educational Background in Biomedical Engineering
Matthew Fronheiser pursued an extensive education in the field of biomedical engineering. He earned his PhD in Biomedical Engineering from Duke University, studying from 2002 to 2007. His undergraduate studies were completed at The Catholic University of America, where he attended from 1998 to 2002. His academic background laid a strong foundation for his subsequent career in the field.
Specialization in Cardiovascular Imaging
Specializing in cardiovascular imaging, Matthew Fronheiser has leveraged his expertise within translational sciences. At Bristol-Myers Squibb, he leads initiatives that focus on advancing cardiovascular imaging technologies and methodologies. His specialization allows him to contribute effectively to the translational sciences division, enhancing the company's capabilities in this critical area.